Literature DB >> 9212725

Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques?

D W Dickson1.   

Abstract

The manuscript by Schmidt et al reports that antibodies generated to paired helical filaments (AMY antibodies) unexpectedly labeled novel non-amyloid, plaque-like structures (AMY plaques) in aged and Alzheimer's disease brains. The full disclosure of the nature of these lesions awaits additional structural and biochemical studies, but at first glance there are interesting parallels between AMY plaques and recently described lesions composed of glia and glia-associated proteoglycans in brains of aged mice. The increasing recognition of the role of proteoglycans in paired helical filaments formation makes proteoglycans or their associated molecules attractive candidates for AMY-immunoreactive proteins. The relationship of AMY plaques to age-related glial changes that some have speculated may be precursors to senile plaques remains to be determined, as is the relationship of AMY plaques to more widely recognized amyloid-containing plaques. Future studies will determine whether AMY plaques are non-amyloid precursors to senile plaques or if they represent an independent type of structural lesion in the Alzheimer's disease brain. Ultimately, the clinical significance of AMY plaques will depend upon their characterization in brains of prospectively studied subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212725      PMCID: PMC1857943     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Authors:  S G Greenberg; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Widespread cytoskeletal pathology characterizes corticobasal degeneration.

Authors:  M B Feany; D W Dickson
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

3.  A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1.

Authors:  M C Kibbey; B Johnson; R Petryshyn; M Jucker; H K Kleinman
Journal:  J Neurosci Res       Date:  1995-10-15       Impact factor: 4.164

4.  Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice.

Authors:  M Jucker; L C Walker; P Schwarb; J Hengemihle; H Kuo; A D Snow; F Bamert; D K Ingram
Journal:  Neuroscience       Date:  1994-06       Impact factor: 3.590

5.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.

Authors:  J H Su; B J Cummings; C W Cotman
Journal:  Neuroscience       Date:  1992-12       Impact factor: 3.590

Review 7.  Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components.

Authors:  S H Yen; W K Liu; F L Hall; S D Yan; D Stern; D W Dickson
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

8.  Early association of reactive astrocytes with senile plaques in Alzheimer's disease.

Authors:  C J Pike; B J Cummings; C W Cotman
Journal:  Exp Neurol       Date:  1995-04       Impact factor: 5.330

9.  FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain.

Authors:  R Bowser; A Giambrone; P Davies
Journal:  Dev Neurosci       Date:  1995       Impact factor: 2.984

10.  Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament.

Authors:  M Novak; J Kabat; C M Wischik
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  4 in total

1.  The AMY antigen co-occurs with abeta and follows its deposition in the amyloid plaques of Alzheimer's disease and down syndrome.

Authors:  C A Lemere; T J Grenfell; D J Selkoe
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.

Authors:  Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Alan J Cross; Donna L Maier; Hank F Kung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-09       Impact factor: 9.236

3.  Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production.

Authors:  Karen S Poksay; Douglas J Sheffler; Patricia Spilman; Jesus Campagna; Barbara Jagodzinska; Olivier Descamps; Olivia Gorostiza; Alex Matalis; Michael Mullenix; Dale E Bredesen; Nicholas D P Cosford; Varghese John
Journal:  Front Pharmacol       Date:  2017-02-15       Impact factor: 5.810

4.  A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.

Authors:  Jesus Campagna; Patricia Spilman; Barbara Jagodzinska; Dongsheng Bai; Asa Hatami; Chunni Zhu; Tina Bilousova; Michael Jun; Chris Jean Elias; Johnny Pham; Gregory Cole; Mary Jo LaDu; Michael E Jung; Dale E Bredesen; Varghese John
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.